Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Skin-on-a-chip devices better mimic human skin for research.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Macrophages are crucial for hair regrowth in contact hypersensitivity.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

The study identified key immune cell differences between mild and severe alopecia areata.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia areata involves immune response and gene changes affecting hair loss.

Plucked hair follicles can help diagnose scalp lupus.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Higher inflammation markers are linked to more severe alopecia areata.